Study Details
Tezepelumab: A Study Drug for Patients with Eosinophilic Esophagitis (EoE)
(IRB#: IRB_00162145)
Eosinophilic Esophagitis (EoE) is a disease that may cause vomiting and heartburn and make swallowing difficult. Tezepelumab is a study drug for patients with EoE. Research is needed to learn if Tezepelumab is safe and effective at helping people with EoE. We also hope to better understand EoE and health problems related to the disease. The information we gain may aid future patients.
- All genders
- Over 18 years old
- Volunteers with special conditions
- In Person
- Paid
Who can participate?
Gender: All genders
Age: Over 18 years old
Volunteers: Volunteers with special conditions
Location: In Person
Inclusion Criteria
- Ages 18 to 80 years old
- Diagnosis of EoE with 2 issues a week 4 weeks before the first visit
- Stable diet for at least 8 weeks before the first visit
- Participants of childbearing age must use specific birth control
- Attend in person at the University of Utah
Exclusion Criteria
- Other disorders related to EoE
- Using a feeding tube
- History of Cancer
- Active serious infection or receiving medications or infection 7 days before the first visit
- Pregnant
Will I be paid for my time?
Yes
IRB#: IRB_00162145
PI: Kathryn Peterson
Department: INTERNAL MEDICINE
Approval Date: 2023-05-10 06:00:00
Specialties: Gastroenterology